Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of carbon nanotubes on pulmonary disorders attributed to occupational and environmental exposures.

Nanomedicine : nanotechnology, biology, and medicine·2025
Same author

DeepBiome: A Phylogenetic Tree Informed Deep Neural Network for Microbiome Data Analysis.

Statistics in biosciences·2025
Same author

Single-Cell and Spatial Transcriptomics Identified Fatty Acid-Binding Proteins Controlling Endothelial Glycolytic and Arterial Programming in Pulmonary Hypertension.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Identification of Coccidioidomycosis Immunoreactive Peptides That Recall T-Cell Responses Indicating Past Exposure.

The Journal of infectious diseases·2025
Same author

Partial Wwox Loss of Function Increases Severity of Murine Sepsis and Neuroinflammation.

bioRxiv : the preprint server for biology·2025
Same author

Treatment of Invasive Pulmonary Aspergillosis and Preventive and Empirical Therapy for Invasive Candidiasis in Adult Pulmonary and Critical Care Patients: An Official American Thoracic Society Clinical Practice Guideline.

American journal of respiratory and critical care medicine·2024

Related Experiment Video

Updated: Jul 2, 2026

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

HIV-Related Lung Disorders.

Homer L Twigg1, Kenneth S Knox

  • 1Division of Pulmonary and Critical Care Medicine, Indiana University Medical Center, Indianapolis, Indiana.

Drug Discovery Today. Disease Mechanisms
|August 19, 2008
PubMed
Summary
This summary is machine-generated.

Highly active antiretroviral therapy (HAART) improves lung immunity in HIV patients. However, it can also lead to new lung complications like immune reconstitution inflammatory syndrome.

Related Experiment Videos

Last Updated: Jul 2, 2026

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
07:21

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment

Published on: June 23, 2019

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Immunology

Background:

  • Human Immunodeficiency Virus (HIV) infection significantly impacts pulmonary health.
  • Highly Active Antiretroviral Therapy (HAART) has transformed HIV patient outcomes.
  • Improvements in the lung microenvironment and pulmonary immunity are noted with HAART.

Purpose of the Study:

  • To review how HIV alters the pulmonary environment.
  • To highlight the effects of HAART on pulmonary perturbations in HIV.
  • To discuss potential lung complications associated with HAART, focusing on immune reconstitution.

Main Methods:

  • Literature review of HIV and pulmonary complications.
  • Analysis of HAART's impact on lung microenvironment and immunity.
  • Focus on pulmonary immune reconstitution inflammatory syndrome (IRIS).

Main Results:

  • HAART enhances pulmonary immunity by preventing immune decline or promoting restoration.
  • New pulmonary complications have emerged in HIV patients on HAART.
  • Pulmonary IRIS is a significant concern related to immune reconstitution.

Conclusions:

  • HAART significantly benefits HIV-infected patients' pulmonary health.
  • Understanding HAART-associated pulmonary complications, particularly IRIS, is crucial.
  • Further research is needed to manage and prevent these emerging complications.